South Korean manufacturer of Sugnentech Inc. It was one of the best performers who jumped 29%on Monday. In Japan, COVID DAIICHI Sankyo vaccine shares increased by 7.4% after the UBS has raised target. In Hong Kong, Shanghai JuSciences Co. shares, which also makes Covid Jabs, has acquired as many as 4.3%.
Increasing cases in Hong Kong and Singapore
The healthcare authorities in the densely populated Hong Kong and Singapore warn that COVID-19 cases cause when the rise wave extends through Asia. China goes on the way to see how last year’s summer peak reaches a mad wave, according to the Chinese Center for Disease Control and Prevention.
“After the recovery of Hong Kong’s normality, the cycles of active periods of COVID-19 survived every six or nine months,” said Edwin Tsui, Hong Kong’s health controller, a press release said. “We expect the COVID-19 activity level to remain at a higher level at least over the next few weeks.”
The Korean Disease Control and Prevention Agency expanded its seasonal vaccination period to two months to the end of June, advising people at the age of 65 and above, most immunity, patients from hospitals and those who are indoors to vaccine with JN.1, shot with Pfizer Inc. and BionTech SE.
“Covid-19 is found not only in winter but also in the summer over the last three years, so it is recommended to get vaccinations as soon as possible to provide a sufficient period of immunity,” KDCA said.
COVID reserves rise
Shares of Korean manufacturers Test-Kit Covid, including Humasis Co., Labgenomics Co., Segene Inc. and SD Biosensor Inc., which were received on Monday. COVID SK BIOSCEANCE CO. ACCOUNT jumped by 7.2%.
“In the pharmaceutical space in pharmaceutical Korea, retail streams remain dominant,” said Gary Tan, a portfolio manager at allspring Global Investments in Singapore. “Retail investors can place the conjuncturally in separate names in the sector.”
Also read: BIGG BOSD 18 tests for COVID-19: “Stay safe and Carry masks”
